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Summary: Using the chromogenic substrate S-2444, the Spectrometric determination of urokinase (EC 3.4.21.31)
in urine subjected to gel filtration was evaluated. Pure urokinase solutions were used to standardize analytical con-
ditions. A low molecular mass (relative molecular mass < 5000) heat resistant (60 min, 97 °C) activity could be
removed from urine by gel filtration (Sephadex G 25 Medium). In the analysis of the high molecular mass fraction
(relative molecular mass > 5000) of urine, amidolysis remained linear during a period of 3 hours. The relation be-
tween enzyme activity and substrate turnover was linear in the range from 0.05-12 U/l. The coefficients of variation
for within-run precision ranged from 1.4—3.8%. The analytical recovery was 98—104%. Average urokinase excretion
in morning urines (collection period 1-3 hours) of 10 heal thy males and 10 heal thy females was respectively 0.82
and 0.68 U/g creatinine.
Spektrometrische Bestimmung von Urokinase mit dem chromogenen Substrat S-2444 im Harn nach Gelfiltration
Zusammenfassung: Es wurden Untersuchungen zur spektrometrischen Bestimmung der Urokinaseaktivität (EC 3.4.
21.31) mit dem chromogenen Substrat S-2444 im Harn nach Gelfiltration vorgenommen. Zur Standardisierung der
analytischen Bedingungen dienten reine Urokinaselösungen. Die Probenvorbereitung durch Gelfiltration (Sephadex
G-25 Medium) ermöglichte die Abtrennung einer kleinmolekularen (< 5000 relative Molmasse), nicht hitzeinaktivier·
baren (60 min, 97 °C) Aktivität aus dem Nativham. Bei Verwendung der großmolekularen Fraktion aus Harn (> 5000
relative Molmasse) verlief die Amidolyse über 3 Stunden linear. Im Bereich von 0,05—12 U/l bestand eine lineare Be-
ziehung zwischen Enzymaktivität und Substratumsatz. Für die Präzision in der Serie betrugen die Variationskoeffi-
zienten 1,4—3,8%. Die analytische Wiederfindung lag bei 98—104%. Bei Untersuchung von je 10 gesunden männ-
lichen und weiblichen Personen betrug die durchschnittliche Urokinaseausscheidung im Mprgenharn (Sammelperiode
1-3 Stunden) 0,82 bzw. 0,68 U/g Kreatinin.
Introduction
The direct Spectrometric determination of urokinase
(EC 3.4.21.31), an endogenous plasminögen activator
excreted in urine (1), with chromogenic substrates (2,
3) offers new diagnostic possibilities (4,5, 6). Like
other proteolytic enzymes the urokinase catalyzes
the amidolytic cleavage of specially synthesized pep-
tide-p-nitroaiiilide derivatives (7), producing coloured
p-nitroaniline which is easily determined at 405 run.
At present the substrates Chromozym® UK (Bz-Val-
Gly-Arg^nitroanilide - HC1), S-2227 (H-Glu-Gly-Arg-
p-nitroanilide - 2 HC1) and S-2444 (< Glu-Gly-Arg-p-
nitroanilide - HC1) are most suited for the amidolytic
determination of the urokinase activity in purified pre-
parations«and in urine. Due to methodological diffic-
ulties, however, measurement in untreated urine
present their own problems (4). This communication
summarizes the results of our studies in order to
evaluate the determination of urokinase with the
chromogenic substrate S-2444 in urine subjected to
gel filtration.
Materials and Methods
Reagents
Chromogenic substrate S-2444 (Kabi Diagnostica, S-11287
Stockholm): Substrate (25 mg) was dissolved in 16.7 ml of
distilled water. Solution of substrate (3 mmol/1) was kept in
aliquots of 1 ml in sterile polystyrene tubes, 16 X 100 mm
(Greiner, D-7440 Nurtingen) in the dark at 2-8 PC. Under
these conditions the solution was stable for at least one month.
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Buffer (pH 8.8 at 25 °C, = 0.05): 6.1 g (50 mmol/1) Tris
(hydroxymethyl)-aminomethane GR (E. Merck, D-6100 Darm-
stadt) and 2.2 g (38 mmol/1) sodium chloride GR (E. Merck,
D-6100 Darmstadt) were dissolved in 800 ml of distilled water.
pH was adjusted to 8.8 at 25 °C by adding an appropriate
amount hydrochloric acid (1 mol/1, Titrisol®, E. Merck,
D-6100 Darmstadt). The solution was adjusted to 1000 ml
with distilled water and pH was checked. 100 ml portions
of buffer solution were stable for at least two months, when
stored at 2-8 °C.
Solvent for urokinase standard preparation: 0,5 g polyethylene-
glycol, type 6000 (Serva, Feinbiochemica, D-6900 Heidelberg)
were dissolved in 100 ml distilled water within 15 min at 37 °C.
Acetic acid GR (E. Merck, D-6100 Darmstadt): 8.33 mol/1.
Aprotinin: Trasylol® (Bayer, D-5090 Leverkusen): 133 Kalli-
krein Inactivator Units aprotinin were added to 10 mi of
buffer for use in the spectrometric assay.
Reagents and preparation methods were in accordance with
recommendations of the substrate manufacturer.
Urokinase solution
Urokinase assay standard (Serono, D-7800 Freiburg i. Br.):
Lyophilized content of one vial (stated activity 2609 ± 30.04
CTA U1) was reconstituted in 10 ml of solvent (5 °C).
Stock solution was either used immediately or aliquots of
0.5 ml were filled into sample cups (Sarstedt, D-5223 Nüm-
brecht, Ref. No. 73641) within 5 min and frozen at -28 °C.
Frozen stock solution was thawed within 5 min at 37 °C.
Freezing, thawing and storage at -28 °C over a period of at
least one month did not alter activity. Appropriate dilutions
of stock solution were also prepared by addition of solvent
(5 °C). If no gel filtration was performed, samples were
diluted with buffer (10 °C) immediately prior to analysis, so
that the conditions resembled those after gel filtration.
collected in a polystyrene tube, 16 X 65 mm (Greiner,
D-7440 Nürtingen) kept in ice. All eluates were analyzed
within 6 min after completion of gel filtration.
Spectrometric determination
The assay was performed in a reaction tube (Brand, D-6980
Wertheim, Cat. No. 780500) at 37 °C. 0.3 ml of sample
(10 °C) was added to 0.6 ml of buffer (37 °C) containing
aprotinin. After a 3 min preincubation period the reaction was
started by addition of 0.1 ml of substrate solution (37 °C).
Reactions were stopped by adding 0.1 ml of acetic acid
after 15 and 180 min. Methodological modifications are
indicated separately. For the determination of the sample
blank, acetic acid and substrate solution were added after
completion of the reaction time. In order to detect spon-
taneous hydrolysis of substrate, additional reagent blanks
were run. Readings of absorbance were performed at 405
nm (light path 10 mm) against water. Generated colour
remained stable for at least 4 hours.
Urokinase activity in U/I was calculated using a value of
1040 m* mof1 for the molar lineic absorbance of p-nitro-
aniline. All activity measurements were performed in duplicate.
Heat resistant activity
For assessment of heat resistant activity the eluates or the ap-
propriately diluted samples were heated in polypropylene
tubes, 16 X 100 mm (Greiner, D-7440 Nürtingen) for 60 min
at 97 °C.
Precision
Within-run precision was calculated from the differences between
duplicates (8). Each of the analyzed urine specimens was sub-
jected to a fivefold gel filtration.
Specimen
Collection and handling: Urokinase in urine is stable in plastic
containers for six hours at room temperature, even without
correction of the pH (4). After an initial voiding, urine was
collected in a plastic bottle over a 3 hour morning period
from 06.00-09.00 a.m. Immediately after collection, urine
was centrifuged in polystyrene tubes, 16 X 100 mm (Greiner,
D-7440 Nürtingen) for 10 min at 1500 £. When untreated
urine was analyzed, the sample was diluted with buffer
(10 °C) corresponding to the conditions after gel filtration.
Equipment
Digital Micro Balance 2406 (Sartorius, D-3400 Göttingen).
Labofuge® III (Heraeus-Christ, D-3360 Osterode).
Water Bath, type 3041 (Köttermann, D-3165 Hänigsen).
pH Meter 22 (Radiometer, DK-2830 Kopenhagen).
Digital photometer 6114 S (Eppendorf Gerätebau,
Netheler + Hinz GmbH, D-2000 Hamburg).
Methods
Gel filtration
Column PD-10, Sephadex G-25 Medium (Pharmacia Fine
Chemicals AB, S-75104 Uppsala) was equilibrated with 50 ml
of buffer. 2.5 ml of sample were added and eluted with
3.5 ml (fraction relative molecular mass > 5000) or 9.5 ml
of buffer (fraction relative molecular mass > 5000 plus
< 5000) respectively. Gel filtration was performed at room
temperature. To prevent loss of activity, the eluate was
1) A CTA unit refers to the standard urokinase unit adopted
by the Committee on Thrombolytic Agents, Nät. Inst, of
Health, Bethesda, Md. USA.
Accuracy
Accuracy was assessed by adding 0.5 ml of urokinase solution
(1.55 U/l, 10 °C) or 0.5 ml of buffer (10 °C) to the investigated
eluates.
Urokinase excretion
For calculation of urokinase excretion in U/g creatinine, the
determination of creatinine concentration (9) in urine was
performed with the Auto Analyzer® I (Technicon Instruments
Corporation, Tarrytown, N.Y.).
Results
Analytical characteristics
Employing urokinase solutions (1000-50000 CTA U/l),
a linear relation was found between the enzyme activity
and the substrate turnover (fig. 1). When the assay was
performed with a constant enzyme activity (10000 CTA
U/l), the amidolysis remained linear during reaction
times from 5 to 180 min (fig. 2).
Recovery after gel filtration
An average recovery of 94.3% was observed after gel
filtration of 10 urokinase solutions (fig. 3). The mean
values (x) of urokinase activity were 1.92 U/l (s; = 0.37
U/l) before and 1.81 U/l (sj = 0.35 U/l) after gel filtra-
tion (fraction relative molecular mass > 5000). When
J. Clin. Chem. Clim Biochem. / Vol. 18,1980 / No. 9
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Fig. 1. Relation between enzyme activity (urokinase assay
standard solution) and substrate turnover (chromogenic
substrate S-2444, reaction time 15 min).
• χ of n = 2
1 2 3
Urokinase (Serono) [U/U
before gel filtration
0.5
,0.3
0.1
Fig. 3. Recovery of enzyme activity after gel filtration (Sephadex
G-25 Medium) of urokinase assay standard solutions
(n = 10, chromogenic substrate S-2444, reaction time
15 min).
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Fig. 2. Relation between reaction time and substrate turnover
(chromogenic substrate S-2444, urokinase assay standard
solution, 10000 CTA U/l).
• x ofn = 3
1 2 3 Λ
Urokinase (urine) [U/l]
before gel filtration
10 urines were analyzed, systematically lower enzyme
activities were found in the high molecular fractions
(relative motecular mass > 5000) after gel filtration
(fig. 4). The average recovery amounted to 84.4%
(x = 1.15 U/l, s* = 0.21 U/l before and x = 0.97 U/l,
ss = 0.20 U/l after gel filtration). From the combined
high and low molecular fractions (relative molecular
mass > 5000 plus < 5000) of a second group of 10
urines, an average recovery (fig. 4) of 98.3 % was ob-
served (x * 1.20 U/l, s* - 0.13 U/l before and χ = 1.18
U/l, s* = 0.14 U/l after gel filtration). To further
characterize the activity present in the low molecular
fraction of urine, the urokinase solutions and both
urine fractions were tested before and after heating
Fig. 4. Recovery of urokinase activity after gel filtration
(Sephadex G-25 Medium) of 20 urines (chromogenic
substrate 8^2444, reaction time 180 min).
ο fraction of relative molecular mass > 5000 (n = 10
urines)
• fraction of relative molecular mass > 5000 plus
<5000(n = 1Q urines)
regression line y = x
for 60 min at 97 °C. 98-100% of the activity present
in the urokinase solutions was inactivated by heating
(tab, 1). In 5 urines (tab. 2), 94.8-98.4% of the heat
labile activity was demonstrable in the high molecular,
and 1.6—5.2% in the low molecular fraction. The pro-
portion of the heat resistant activity in the high mole-
cular fraction amounted to only 0.01—0.06 U/L
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Tab. 1. Activity of urokinase solutions before and after heating
(60 min, 97 °C).
Urokinase
solution
(Urokinase
assay standard,
Serono)
No.
1
2
3
4
5
6
7
Urokinase activity
(EC 3.4.21.31)
before
heating
[U/l]
1.32
1.64
2.63
3.16
3.98
4.20
4.61
after
heating
[U/l]
0.000
0.016
0.000
0.032
0.000
0.000
0.092
Heat-labile
activity
[%]
100
99
100
99
100
100
98
s|J
Ο «Ξ
2- Ό
01
Ο 1 2 3
Urpkinase(urine) after gel filtration [U/l]
(Reaction time 15min)
Reliability of urokinase determinations in urine
subjected to gel filtration
Compared with the activity measured at 15 min, the
activity measured after 180 min incubation (fig. 5) was
6% lower for simultaneous determinations on the high
molecular fractions of 15 urines (after 15 min χ = 0.84
U/l, s^ = 0.16 U/l, after 180 min χ = 0.79 U/l, s^ = 0.15
U/l). A linear relation could be demonstrated between
the sample volumes and the substrate turnover at reac-
tion times of 15 and 180 min, when 0.1-0.3 ml of
sample were employed in the assay (fig. 6). The coeffi-
cients of variation for the within-run precision ranged
from 1.4-3.8% (tab. 3). The recovery was 98.2-104%
after addition of 1.55 U/l urokinase (tab. 4).
Preliminary reference values for urokinase excretion
in urine
When morning urines (collection period 1-3 hours) of
20 healthy individuals (10 males, median of age 37
years, range 32-46 years; 10 females, median of age
34 years, range 26-53 years) were analyzed, the ob-
served urokinase activities ranged from 0.18-2.57 U/l.
The average urokinase excretion in U/g creatinine
in urine amounted to 0.82 U/g (range 0.43-1.07)
in the males and 0.68 U/g (range 0.42-1.10 U/g)
in the females.
Fig. 5. Recovery of urokinase activity (chromogenic substrate
S-2444) in 15 urines subjected to gel filtration (Sephadex
G-25 Medium) after prolongation of reaction time from
15 to 180 min.
regression line y = χ
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Ε
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Fig. 6. Relation between sample volume (urine subjected to
gel nitration, Sephadex G-25 Medium) and substrate
turnover (chromogenic substrate S-2444).
• x" of 10 urines (reaction time 15 min)
ο χ of 10 urines (reaction time 180 min)
Tab. 2. Amidblytic activity before and after heating (60 min, 97 °C) of high and low molecular fractions of urines subjected to gel
filtration (Sephadex G-25 Medium).
Urine Amidolytic activity
Fraction relative molecular mass
No.
1
2
3
4
5
>5000
before
heating
[U/l]
1.31
1.20
1.61
1.87
0.61
>5000
after
heating
[U/l]
0.03
0.06
0.04
0.03
0.01
. . < 5000
before
heating
[U/l]
0.20
0.18
0.16
0.13
0.08
<5000
after
heating
[U/l]
0.13
' 0.13
0.13
0.10
0.06
Heat-labile activity
Fraction relative molecular mass
>5000
4- < 5000
[U/l]
1.35
1.19
1.60
1.87 .
0.62
>5000
[%]
94.8
95.8
98.1
98.4
96.8
<5000
[%)
5.2
4.2
1.9
1.6
3.2
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Tab. 3. Within-run precision of spectrometric determination of
urokinase with chromogcnic substrate S-2444 in urine
subjected to gel filtration (Sephadex G-25 Medium).
Urine subjected
to gel filtration
No.
1
2
3
4
5
6
Number of
determinations
(Duplicates)
n
5
5
5
5
5
5
Urokinase
activity
(EC 3.4.21.31)
X[u/n
0.48
0.72
0.87
1.41
2.34
2.66
Coefficient
of variation
l%]
3.8
3.6
2.1
2.2
1.4
1.4
Tab. 4. Accuracy of spectrometric determination of urokinase
with chromogenic substrate S-2444 in urine subjected to
gel filtration (Sephadex G-25 Medium).
Urine
subjected to
gel filtration
No.
1
2
3
4
5
Urokinase activity
(EC 3.4.21.31)
after addition of 1.55 U/l
expected measured
lU/1) [U/l]
2.17 2.14
2.21 2.17
2.41 2.47
2.50 2.60
3.79 3.88
Deviation
from
expected
value
1Δ%]
-1.4
-1.8
+ 2.5
+ 4.0
+ 2.4
Discussion
At the present time the chromogenic substrate S-2444
is the substrate of choice for the determination of uro-
kinase (10,11). Using urokinase solutions the linearity
was assessed (fig. 1 and 2) in the low range of activity
from 1000-50000 CTA U/l, corresponding to 0.16-8.0
U/l, because activities of 0.50-0.90 U/l were observed
in the morning urines of healthy individuals with the
substrate Chromozym® UK (5). To increase the sensi-
tivity, 0.3 ml of diluted sample were employed in the
assay. This was in contrast to the substrate manur
facturer's original laboratory instructions, which re-
commend a sample volume of 0.1 ml. The dilution of
the sample (factor 1.4) corresponded with the condi-
tions after gel filtration. In addition the reaction time
was prolonged from the original 5 rnin to 15 and 180
min respectively. The molar absorbance of p-nitro-
aniline depends .on the reaction conditions (12). At
present the applied value of 1040 m2 - mol"1 for the
molar lineic absorbance pfp-nitroaniline seemed to
be a suitable compromise.
The average recovery in the macromolecular fraction
after gel filtration of 94.3% for the original activity of
pure urokinase solutions (fig. 3) is acceptable. For the
column PD-10, Sephadfcx G-25 Medium, a recovery of
95.3% is stated by the manufacturer, if human serum
albumin (25 mg) dissolved in NaCl solution (0.5 mol/1,
2.5 ml) is used. The distinctly lower average recovery
of enzyme activity (84.4% of the activity in the un-
treated urines) observed in the high molecular urine
fractions (fig. 4) was unexpected. The reported values
(1) for the relative molecular masses of urokinase ex-
creted in urine are 31500 (Si-type) and 54700
(S2-type). Therefore it was supposed, that a low mole-
cular activity (relative molecular mass < 5000) must be
present in the untreated urine. This was confirmed by
the average recovery of 98.3% of the original activity,
when the combined high and low molecular fractions
of uttnes were investigated (fig. 4). In contrast to the
activities present in the urokinase solutions and in the
high molecular fractions of urines (tab. 1 and 2), the
activity of the low molecular fraction of urine (tab. 2)
could not be inactivated by heating for 1 hour at 97 °C,
as reported recently (13). The nature of the low mole-
cular, heat resistant activity is unknown. A non enzy-
matic interference, e.g. from salts or urochromes, is
possible.
For the determination of urokinase in urine subjected
to gel filtration, analytical conditions identical to those
chosen for the urokinase solution were applied. The
activities measured simultaneously after reaction times
15 and 180 min differed to an extent, which is negli-
gible for practical purposes (fig. 5). The observed
linearity of the amidolysis for the high molecular urine
fraction within 3 hours corresponds with the results
of other investigators for the analysis of untreated urine
using the substrate Chromozym® UK (4, 6). For
reaction times of 15 and 180 min, the increase of the
sample volume from 0.1 ml—0.3 ml caused no loss of
linearity in the range 0.54-1.62 U/l, or 0.34-1.02 U/l
(fig. 6). The results presented indicate a linear relation
between the substrate turnover and the enzyme activity
in the range 0.05-12.2 U/l, if 0.3 ml of sample and a
reaction time of 180 min are employed. Aprotinin was
added to increase the specifity (4, 5). The within-run
precision and the accuracy of the urokinase measure-
ments in urine subjected to gel filtration were com-
parable to those of serum enzyme determinations.
The reference values for the urokinase excretion in
urine reported here are considered to be preliminary.
Conclusions regarding sex related differences of uro-
kinase output should not be drawn from these data. The
urokinase excretion was calculated in U/g creatinine, in
order to compensate for the influence of different
volumes of urine.
The spectrometric determination of urokinase with the
chromogenic substrate S-2444 represents a practicable
method for the measurement of urokinase activity in
pure solutions and in urine subjected to gel filtration.
By gel filtration, a low molecular heat resistant activity
can be removed from the untreated urine. As with other
determinations of enzyme activities in urine (14, 15),
the additional work load of gel filtration is therefore con-
sidered to be acceptable. Comparative investigations
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with the conventional methods for the determination
of the urokinase activity are still lacking. A final judge-
ment on the diagnostic significance of the amidolytic
measurement of the urokinase activity in the field of
urine enzymology (16) can not be passed until greater
populations of patients have been investigated.
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